即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 357336-20-0 | 货号 | BCP14251 |
中文名 | 布瓦西坦 | ||
英文名 | Brivaracetam | ||
中文别名 | |||
英文别名 | UCB 34714;UCB-34714;UCB34714; Briviact; | ||
SMILES | |||
化学名称 | |||
分子式 | C11H20N2O2 | 分子量 | 212.29 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Brivaracetam has been tested in a comprehensive safety pharmacology, toxicology, developmental toxicology, and genotoxicity program. It is of low acute toxicity, target organ for toxic effects is the hepatobiliary tract. Carcinogenicity studies are ongoing. Human pharmacology studies have shown that brivaracetam has a half-life of 8 h and nearly complete bioavailability . CSD episodes were regularly elicited on slices upon delivery of calibrated KCl drops and were recorded via two micropipette electrodes. After control CSDs, the drug was added to the perfusion and five subsequent CSDs were elicited during drug perfusion. Effects were assessed via CSD amplitude (Ampl) and duration at half-amplitude (D(1/2)). BRV, 10 and 32 microM reduced the Ampl and transiently the D(1/2). Levetiracetam, 32 and 100 microM had no effect on either Ampl or D(1/2) . Brivaracetam bound selectively with 20 fold higher affinity than levetiracetam to SV2A . BRV produced a concentration-dependent inhibition of |
Tags:Brivaracetam 供应商,Brivaracetam 购买,Brivaracetam 生产,Brivaracetam 批量,Brivaracetam 供应,Brivaracetam 订购,Brivaracetam 采购